Precise Personalized Medicine in Gynecology Cancer and Infertility

Pu-Yao Zhang; Yang Yu

doi:10.3389/fcell.2019.00382

Precise Personalized Medicine in Gynecology Cancer and Infertility

Front Cell Dev Biol. 2020 Jan 17:7:382. doi: 10.3389/fcell.2019.00382. eCollection 2019.

Authors

Pu-Yao Zhang^{1

2

3}, Yang Yu^{1

2

3}

Affiliations

¹ Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.
² Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China.
³ Key Laboratory of Assisted Reproduction, Ministry of Education, Peking University Third Hospital, Beijing, China.

Abstract

Since the conception of precision medicine has been put forward in oncology, this idea has been popularized and applied in many specialties. Significant progress has been made toward personalizing the entire process, including diagnosis, treatment planning, and embryo identification, and combining large-scale genetic information data and knowledge discovery can offer better prospects in reproductive medicine. This work reviews the application of precision medicine and possibilities in reproductive medicine and gynecologic cancer diagnosis and treatment. The limitations and challenges of precision medicine in this area remain to be discussed.

Keywords: embryo; gynecologic cancer; large-scale data; precision medicine; reproductive medicine.

Publication types

Review